NovaMed Inc.

Thomas S. Hall has served as President and Chief Executive Officer of NovaMed Inc., and has been a member of our Board of Directors, since November 14, 2005. Mr. Hall was appointed Chairman of the Board on February 21, 2007. From April 2003 to November 2005, Mr. Hall served as President and Chief Operating Officer of Matria Healthcare, Inc., after having joined Matria in October 2002 as Executive Vice President and Chief Operating Officer. Matria provides disease management programs to health plans and employers. From 2000 to 2002, Mr. Hall was President and Chief Executive Officer of TSH & Associates, an independent consulting and management services company. From 1997 to 1999, Mr. Hall held several executive positions that included President of ADP TotalSource, a division of Automated Data Processing, Inc. (ADP). Mr. Hall also served in senior management positions with Riscorp, Inc., an insurance holding company, and USAir Express/Chautauqua Airlines. A native of Upstate New York, Mr. Hall earned a BA in business from Goshen College and an MBA from Clarkson University.

E. Michele Vickery joined NovaMed in March 1997 and serves as Executive Vice President Operations. From 1990 to 1996, Ms. Vickery was employed by Surgical Care Affiliates (SCA), a company specializing in the management of outpatient surgery centers, as a Regional Vice President from 1990 until 1992, and as one of two Senior Vice Presidents of Operations from 1992 to 1996. Upon the acquisition of SCA by HealthSouth in 1996, Ms. Vickery continued as a Senior Vice President of the Surgery Division of HealthSouth until joining NovaMed. Ms.Vickery received her B.A. from Wittenberg University, and her B.S.N. from Case Western Reserve University.

John W. Lawrence, Jr. has served as NovaMed's Corporate Counsel since 1996. Mr. Lawrence is responsible for all legal matters relating to NovaMed and its operations, including structuring and negotiating all development transactions. Prior to joining NovaMed, Mr. Lawrence was an associate at the law firm of Katten Muchin Zavis. Mr. Lawrence's background is in general corporate practice, with a focus in mergers and acquisitions. From 1992 to May 1995, Mr. Lawrence was an associate with the law firm of Seyfarth, Shaw, Fairweather & Geraldson. Mr. Lawrence received his B.A. in Economics from the University of Michigan in 1988, and his J.D. with honors from Washington University School of Law in 1992.

Robert C. Goettling has held a variety of positions at NovaMed both in corporate development and operations. Presently, Mr. Goettling is Senior Vice President of Corporate Development and is responsible for the acquisition of new ASCs, the syndication of existing ASCs and the development of new ASC build projects. Mr. Goettling has been with NovaMed since its inception and has conducted numerous practice and ASC acquisitions in addition to leading several practice unwind transactions. More recently, Mr. Goettling has been instrumental in NovaMed's ASC syndication transactions and until May of 2003 had operational responsibility for our Southeast Region. Prior to joining NovaMed, Mr. Goettling served as the Executive Vice President of Midwest Uncuts, Inc., a national optical laboratory. From 1991 to 1995 he served as the Chief Operating Officer for the Chicago division of Midwest Uncuts. Mr. Goettling was a co-founder of Midwest Uncuts Chicago in 1990 and served as its President and Chief Executive Officer from 1991 until its merger with Midwest Uncuts. He was also a principal in TRI-OC Management, Inc., an optical management company. Prior to co-founding Midwest Uncuts Chicago, Mr. Goettling practiced law with Katten Muchin & Zavis in Chicago. Mr. Goettling received his B.S.B.A. cum laude in Economics from Creighton University in 1985, and his J.D. from the University of Notre Dame Law School in 1988.

William J. L. Kennedy serves as NovaMed's Senior Vice President Business Development. Mr. Kennedy is responsible for various strategic and development projects. He oversees the due diligence and acquisition analysis unit. He joined NovaMed in January 1996 as Vice President of Acquisitions. From 1992 to 1995, Mr. Kennedy was Regional Manager of CIT Group/Business Credit where he successfully rebuilt the Chicago office by restructuring a troubled portfolio, upgrading the staff and refocusing the marketing effort. Previously, Mr. Kennedy was a principal and founder of his own firm specializing in consulting and investing in middle-market companies. From 1981 to 1990, Mr. Kennedy was with Citicorp in a variety of positions, most recently as a Senior Credit Officer & Manager of the Midwest and Canadian Region of the Leveraged Capital Group where he built a $1 billion portfolio with after-tax earnings exceeding $10 million. Mr. Kennedy has completed over 80 middle-market transactions. He received his A.B. degree from Colgate University in 1973, and M.B.A. from Harvard Business School in 1977.

Frank l. Soppa joined NovaMed in June of 1999 and serves as Vice President of the Optical Services Group. Mr. Soppa directs the Operations of the Optical Laboratories, the Alliance which is NovaMed's centralized optical purchasing organization, and optometric business. Mr. Soppa has been involved in the eyecare industry for over 20 years. The majority of his career was with LensCrafters, where he was employed for 13 years, holding senior management positions in the Operations, Optometric Services and New Concept Development areas. Mr. Soppa received his B.A. in Business Administration in 1984 from Metropolitan State University, St. Paul, Minnesota.

John P. Hart joined NovaMed as Vice President, Corporate Controller in September 2003. Mr. Hart is responsible for NovaMed's financial and operational accounting, external/internal financial reporting, and budgeting/financial analysis to support operations. Prior to joining the Company, Mr. Hart was Vice President, Assistant Corporate Controller for Information Resources, Inc., a $560 million, publicly traded, market research company located in Chicago, Illinois. Mr. Hart has over 15 years of accounting/finance professional experience and has held various corporate accounting and internal audit management positions in the Chicago area. Mr. Hart began his career at Ernst and Young LLP, received his B.B.A. degree in accounting from Loyola University of Chicago, and is a Certified Public Accountant.

Robert J. Kelly joined NovaMed's Board of Directors in April 2004, served as non-executive Chairman from October 2005 until he was appointed Lead Director in February 2007. He has spent over 30 years in finance and general management and is currently an independent consultant. From 2000 to 2001, Mr. Kelly served as Executive Vice President and Chief Financial Officer of Celarix, Inc., a company that provides enterprise level solutions of logistics over the Internet. From 1997 to 2000, Mr. Kelly served as Chief Financial Officer of Summit Autonomous, Inc., a manufacturer of excimer lasers that was acquired by Alcon Laboratories, Inc. in 2000. Previously, from 1992 to 1997, Mr. Kelly served as Chief Financial Officer of Bull HN Information Systems, Inc., the U.S. subsidiary of Groupe Bull, an international information technology company based in France. A native of Massachusetts, Mr. Kelly holds a BS in Mathematics from the University of Massachusetts and a MBA from the Harvard Business School.

Mr. Piccolo has been a director of the Company since November 2000. Mr. Piccolo has been the President and Chief Executive Officer of HealthPic Consultants, Inc., a strategic healthcare consulting firm, since 1997. From November 2004 to November 2006, Mr. Piccolo served as Chairman and Chief Executive Officer of Benchmark Medical, Inc., a provider of outpatient physical rehabilitation services, and he continues to serve as a director. In 1996 Mr. Piccolo served as Chairman and Chief Executive Officer of Caremark International, Inc. Mr. Piccolo also currently serves as a director of Chemtura Corporation, a polymer and specialty products manufacturer, and as a director of CVS/Caremark Corporation, an integrated pharmacy services provider. Mr. Piccolo serves on the Board of Trustees for Lake Forest Hospital.

C.A. Lance Piccolo has been a member of NovaMed's Board of Directors since 2000. Mr. Piccolo was Chairman and Chief Executive Officer of Caremark International, Inc. from 1992 through 1996, following its spin-off from Baxter International, Inc. Mr. Piccolo continues to serve as Vice Chairman of Caremark Rx, Inc. (NYSE: CMX), a leading prescription benefits management firm. Over Mr. Piccolo's distinguished 25-year career at Baxter, he progressed through a series of sales, operating and executive positions, including Executive Vice President for over five years. He was responsible for Baxter's alternate site operations and oversaw its development into one of the industry leaders. He was also a member of Baxter's Board of Directors from 1988 through 1992. Since 1996, Mr. Piccolo has served as President and Chief Executive Officer of HealthPic Consultants, Inc., a strategic health care consulting firm. Additionally, he serves on the Board of Directors of Crompton Corporation (NYSE: CK), Physician Dynamics, Inc., Benchmark Medical, Inc., Wind Point Partners, National Nephrology Associates, Inc., MedAssets Advisory Board and Lake Forest Hospital Foundation. He is also a member of the board of trustees of the University of Chicago Hospitals and the Advisory Board of Northwestern University, Kellogg Graduate School of Management.

Scott H. Kirk, M.D. has been a member of NovaMed's Board of Directors since August 1995. Dr. Kirk has practiced ophthalmology in the Chicago area since 1982, and has been the Medical Director at SureVision Eye Centers in River Forest, Illinois since 1987. Dr. Kirk is an assistant clinical professor at the University of Illinois and is on the medical staff at West Suburban Hospital, Oak Park Hospital and Gottleib Memorial Hospital. Dr. Kirk has served as a site surveyor for the AAAHC since 1991 and is a current member of the AAAHC Board of Directors. Dr. Kirk is certified by the American Board of Ophthalmology and is a Fellow of the American Academy of Ophthalmology. Dr. Kirk is also a director of the Outpatient Ophthalmology Surgical Society. Dr. Kirk earned his M.D. from Washington University Medical School in 1978 and completed his residency there in 1982.

Scott T. Macomber joined NovaMed as Executive Vice President and Chief Financial Officer in October 2001. Mr. Macomber is responsible for NovaMed's financial management, treasury and reporting functions. Prior to joining the company, Mr. Macomber was Senior Vice President and Chief Financial Officer of Extended Care Information Network, Inc., a health care information technology company located in Northbrook, IL. In 1999, Mr. Macomber served as Executive Vice President and Chief Financial Officer of PeopleServe, Inc., a $200 million privately held health services provider located in Dublin, OH. From before its initial public offering in 1992 through 1998, Mr. Macomber served as Senior Vice President and Chief Financial Officer of Vitalink Pharmacy Services, Inc., a $500 million New York Stock Exchange-listed institutional pharmacy provider. Mr. Macomber also spent 12 years in various financial, acquisition and development positions at Manor Care, Inc., one of the largest long-term care providers in the industry. Mr. Macomber received his B.A. degree from the University of Vermont in 1976 and M.B.A. from the University of Michigan in 1979.

Steve Napolitano is a corporate partner of Winston & Strawn's Chicago office and co-chair of the firm's private equity practice. During his 21 years of experience, Mr Napolitano has focused his practice on representing private equity funds, emerging growth companies and senior management teams in connection with transactions involving mergers, acquisitions, leveraged buyouts, mezzanine financings, venture capital financings and corporate restructurings. His substantial experience includes private equity matters involving private and public targets, including management-sponsored going-private transactions, and complex management equity arrangements. Mr Napolitano has particular experience with leveraged buyout, M&A and venture capital transactions in the regulated for profit healthcare sector. Mr Napolitano's recent engagements include: the representation of Wind Point Partners in connection with the leveraged buyout of Omniflight and affiliates; the representation of Arr-Maz Custom Chemicals in connection with the acquisition of certain US and French subsidiaries of NuFarm, an Australian public company; the sale of Arbor Private Investment Company's Arriba Foods portfolio company to Hormel; and the sale of Wind Point Partners' Ames True Temper portfolio company to a new entity formed by Castle Harlan Partners. Since 2003, Mr Napolitano has been named in both Chambers Global: World's Leading Lawyers and Chambers USA: America's Leading Business Lawyers as one of the leading private equity and corporate mergers and acquisitions lawyers in the US. Mr Napolitano was recently cited by The Best Lawyers in America, 2006 edition, as a leading lawyer in the fields of mergers and acquisitions, and private equity law and leveraged buyouts. He also has been recognized as an Illinois Super Lawyer in mergers and acquisitions. In October 2005, the Chicago Sun Times profiled Mr Napolitano as one of the top five private equity lawyers in Chicago. In addition to his professional accomplishments, Mr Napolitano is involved in several professional and philanthropic organizations. He serves on the board of directors of NovaMed Eyecare Inc (Nasdaq: NOVA). He also serves on the boards of directors of the Malignant Hyperthermia Association of the US (MHAUS) and United Cerebral Palsy of Chicago, where he is a vice-chairman and a member of the executive and operating committee. Mr Napolitano is also a regular speaker at various private equity and M&A focused industry conferences. Mr Napolitano graduated with a BA in economics from the University of Notre Dame, where he was elected to Omicron Epsilon Delta. He earned his JD from Boston University School of Law, where he was a G Joseph Tauro Scholar and an American Jurisprudence Award recipient. He also served as an editor of the American Journal of Law and Medicine.